Pathology lab property finance

Ardent Capital Group brings the same method to every client: execution and strategy, clear advice for smart lending, and long-term growth. That means the right lender, structure and timing, straight advice so you borrow with confidence, and today's deal built toward where you want to be tomorrow. We are specialists in helping business owners secure finance to purchase their own property, and we understand the complex structures that often sit around it, including multiple trusts, holding companies and self-managed super funds. A lab carries specialised services like power redundancy, dedicated drainage and clean areas, so we take it to lenders who read a purpose-built clinical building on its merits rather than pricing it as ordinary office space. Owning the premises protects a fit-out that is costly to relocate, and we stay alongside you as new tests and new locations arrive. Every figure is subject to serviceability, lender appetite and approval.

Going direct to one lender means a single credit appetite and a single answer, and a pathology laboratory is a specialised licensed asset that many lenders assess conservatively. Some will not lend against a purpose-built lab at all, while others price it on a specialised-use basis and step the LVR down. A specialist broker knows which lenders understand NATA-accredited laboratories and collection-centre networks, and how to present the building, the equipment and the operating entity so it gets approved. You reach the lenders that fit how you trade, so you do not have to knock on every door, rather than collecting declines.

Expect an owner-occupier LVR of around 60% to 70%, reflecting the conservative specialised-use valuation on purpose-built fit-out. An investment-leased lab usually sits a little lower again. The strength of the operator moves the number most, so talk to us and we will size it against your file.

Valuers treat a pathology laboratory as a specialised-use asset. Purpose-built inclusions such as benches, biosafety and fume cabinets, cold and cryo storage rooms and backup power are largely non-transferable to a different occupier, so they are discounted below cost and the valuation steps down from what the fit-out spent. That conservative basis is the main reason the owner-occupier LVR sits around 60% to 70% rather than the higher bands a standard commercial building attracts. We brief the valuer on the accreditation and the tenant covenant so the assessment is fair.

Analysers, biosafety cabinets, cold and cryo storage and backup power are depreciating plant, not part of the building, so lenders fund them on their own terms rather than inside the property loan. Keeping the equipment on separate asset finance protects the property security, matches each facility to the life of what it funds, and stops a valuer discounting single-use kit inside the mortgage. It also lets you refresh analysers on a chattel mortgage or rental line without touching the property facility. We structure the building loan and the equipment finance side by side.

Most pathology operators run a central hub laboratory that processes samples and a network of collection centres that gather them, and the two are financed differently. The hub is a specialised licensed asset assessed on a specialised-use basis, while a collection centre is closer to a small retail-style tenancy and is read on its lease and location. We can fund a single collection-centre premises, the hub laboratory, or the network as a whole, and we present each site so its own security and income are underwritten correctly. Corporate and trust ownership across the network is common and we structure for it.

Owner-occupier finance applies when your own operating entity runs the laboratory from the premises, and the lender assesses the business income alongside the specialised-use valuation, lending around 60% to 70%. Investment-leased finance applies when you hold the building as an asset and lease it to a pathology operator, so the lender focuses on the lease term, the rent and the strength of the tenant covenant. Investment LVRs are usually a little lower again, and a long lease to a strong corporate operator makes the asset far easier to fund.

Yes, it is possible, and we arrange these. It is also one of the more intricate purchases in commercial finance, and the detail is what decides whether it works. The fund borrows under a limited recourse borrowing arrangement, so the laboratory sits in a separate holding trust and the lender can only come after that one property. From 10 August 2026 a new arrangement can only be used for business real property: a property trading wholly as a business generally qualifies, a property with a residence attached generally does not. Your operating company leases the laboratory back from the fund, in writing, at market rent supported by an independent appraisal, and the rent has to actually be paid. SMSF lending caps well below a standard purchase, so the fund provides its own deposit and the full-price funding available outside super does not apply here. Cross-collateralisation is not available inside super either. Lenders cap SMSF lending below a standard purchase, generally between 65% and 75%, and want cash left in the fund after settlement. We know this sounds complicated. It is, and that is exactly why we do it every day. Reach out to our team and we will guide you through the entire process. We structure the finance, tell you which lenders will take a pathology laboratory as SMSF security and on what terms, and bring in the SMSF specialists and licensed advisers who set the fund side up. You will not be working it out on your own. Get that right and it is a solid, compliant structure.

A specialised licensed asset skews longer than a standard commercial purchase because the valuation and the lender's credit assessment both take more work. Most clients receive indicative terms within a few days of our first conversation, with formal approval commonly running three to six weeks with a bank and two to four weeks with a non-bank, and the specialised valuation can add time. Corporate structures, network purchases and SMSF arrangements have more moving parts again. We give you a realistic timeline upfront so your settlement date holds.

For a full-doc application, most lenders want two to three years of financial statements and tax returns for the operating entity, personal returns for the guarantors, the contract of sale, and the lease where the laboratory is leased to an operator. Where a corporate or trust owns the asset, the deed or constitution and its financials are needed too. Many operators do not fit a standard full-doc assessment, so non-bank alt-doc and low-doc options let income be evidenced through an accountant's declaration, BAS statements or bank statements. These carry slightly higher rates but open the door where the paperwork understates income, and we work through your position upfront to identify the best approach.

Often, yes. A decline usually reflects one lender's policy on specialised assets rather than a deal that cannot be funded. Banks apply rigid credit rules, and a purpose-built laboratory valued on a specialised-use basis does not always fit them. Non-bank lenders and specialist financiers assess these assets differently, and sometimes a structuring or presentation issue is all that stood between you and an approval. We will give you an honest assessment of what is achievable before proceeding.

Most of the time, no. We are paid a commission by the lender once your loan settles, so there is no cost to you. Where your financials are complex, the structure is unusual, or a specialised asset requires significant preparation before it can go to a lender, we may charge a small mandate fee depending on the complexity. We will always be upfront about this before any work begins.

Although we are based in Sydney, we service clients across all major Australian cities, including Melbourne, Perth, Brisbane, the Gold Coast, Adelaide, Canberra and Hobart, along with their surrounding regional areas. Wherever your pathology laboratory or collection centre is located, we can arrange your finance.

Although our main speciality is property loans for business owners, we also assist with pathology lab equipment finance and working capital for pathology labs. On asset finance, that covers laboratory equipment such as analysers, biosafety cabinets, cold and cryo storage and backup power. On working capital, we arrange business overdrafts, lines of credit and cash-flow funding to cover reagents and consumables, wages and the timing of Medicare pathology claims.

Yes. That is our core ethos, helping you understand the right strategy, structure and clear advice from the very first conversation. Our main borrower profiles are established pathology operators and practice owners seeking finance from $100,000 upwards for their company, so a first commercial loan is well within our wheelhouse. Smaller sole-trader and consumer-style ABN lending sits outside our field.